Alec Stranahan

Stock Analyst at B of A Securities

(0.83)
# 3,973
Out of 5,045 analysts
31
Total ratings
41.67%
Success rate
-24.53%
Average return
Main Sectors:

Stocks Rated by Alec Stranahan

Krystal Biotech
Oct 17, 2025
Maintains: Buy
Price Target: $182$255
Current: $189.08
Upside: +34.86%
Candel Therapeutics
Sep 3, 2025
Downgrades: Neutral
Price Target: $13$7
Current: $5.58
Upside: +25.45%
Xencor
Sep 3, 2025
Downgrades: Neutral
Price Target: $23$12
Current: $14.13
Upside: -15.07%
Erasca
Sep 3, 2025
Downgrades: Underperform
Price Target: $4$1
Current: $2.46
Upside: -59.35%
Novavax
Aug 20, 2025
Downgrades: Underperform
Price Target: $9$7
Current: $8.43
Upside: -16.96%
Beam Therapeutics
Mar 28, 2025
Upgrades: Buy
Price Target: $42
Current: $23.80
Upside: +76.47%
Day One Biopharmaceuticals
Jan 7, 2025
Maintains: Buy
Price Target: $28$25
Current: $7.04
Upside: +255.11%
Caribou Biosciences
Jan 7, 2025
Maintains: Buy
Price Target: $13$11
Current: $2.32
Upside: +374.14%
Perspective Therapeutics
Nov 25, 2024
Downgrades: Neutral
Price Target: $24$6
Current: $2.64
Upside: +127.27%
Editas Medicine
Aug 8, 2024
Upgrades: Buy
Price Target: $13$15
Current: $3.01
Upside: +398.34%
Maintains: Buy
Price Target: $48$55
Current: $58.87
Upside: -6.57%
Maintains: Underperform
Price Target: $5$6
Current: $34.02
Upside: -82.36%